Showing results (2041-2050 of 2,659) with videos related to

Sort By:
Pageof 266
Pharmacotherapy|March 1, 1994
Evaluation of ketorolac, ibuprofen-paracetamol, and dextropropoxyphene-paracetamol in postoperative painM U Naidu, T R Kumar, U S Jagdishchandra, et al.
Journal of the American Geriatrics Society|October 19, 2017
Secondary Prevention Medication Use After Myocardial Infarction in U.S. Nursing Home ResidentsAndrew R Zullo, Sadia Sharmin, Yoojin Lee, et al.
The Journal of Surgical Research|December 21, 2016
Predictors of residual disease after unplanned excision of soft tissue sarcomasAlicia A Gingrich, Alexandra Elias, Chia-Yuan Michael Lee, et al.
Implementation Science : IS|January 24, 2014
Designing and evaluating an interprofessional shared decision-making and goal-setting decision aid for patients with diabetes in clinical care--systematic decision aid development and study protocolCatherine H Yu, Dawn Stacey, Joanna Sale, et al.
Human Genomics|September 1, 2024
Characterizing PFAS hazards and risks: a human population-based in vitro cardiotoxicity assessment strategyLucie C Ford, Hsing-Chieh Lin, Yi-Hui Zhou, et al.
Diabetes & Metabolism|June 6, 2022
The prognostic value of the oral glucose tolerance test for future type-2 diabetes in nulliparous pregnant women testing negative for gestational diabetesLiran Hiersch, Baiju R Shah, Howard Berger, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 17, 2024
Mechanisms of spinophilin-dependent pancreas dysregulation in obesityKaitlyn C Stickel, Nikhil R Shah, Emily T Claeboe, et al.
BMC Neurology|July 9, 2013
Risk factors, quality of care and prognosis in South Asian, East Asian and White patients with strokeNadia A Khan, Hude Quan, Michael D Hill, et al.
The Journal of Rheumatology|October 1, 1984
D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3P Emery, G S Panayi, G Huston, et al.
EMBO Molecular Medicine|January 6, 2010
Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's diseaseAnne M Fagan, Mark A Mintun, Aarti R Shah, et al.
Pageof 266